IL16 and neoplasm: Expression of IL-16 has been described in several peripheral cancers such as breast and prostate cancer33, 34; mechanistic studies are scarce, but it can be speculated that IL-16 contribute to inflammation at tumour sites, for instance by recruitment of leucocytes33, 35.